Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

A new approach to treating post-traumatic stress disorder (PTSD) has received FDA clearance, offering a personalized alternative for people who have not found sufficient relief through existing treatments. Developed by California-based Wave Neuroscience in collaboration with researchers at the Texas A&M Health Institute of Biosciences and Technology, the technology uses brain activity measurements to guide targeted magnetic stimulation.

1. Homepage
2. Science
3. Breakthrough PTSD treatment achieves 68% remission rate in clinical trial